| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Madrigal Pharmaceuticals, Inc. | $505.75 | 1.2% | $11.66B | -39.4 | 29.1% | — | Healthcare | 78.9% | 256.8% | ||
| 2 | Metsera, Inc. | $70.50 | 0% | $7.43B | -34.7 | — | — | Healthcare | 154.4% | — | ||
| 3 | Rhythm Pharmaceuticals, Inc. | $96.79 | 1% | $6.63B | -31.1 | -13% | — | Healthcare | 57.4% | 58.7% | ||
| 4 | Terns Pharmaceuticals, Inc. | $52.95 | 0% | $4.77B | -51.4 | 8.8% | — | Healthcare | 1223.8% | — | ||
| 5 | Akero Therapeutics, Inc. | $54.65 | 0% | $4.5B | -14.6 | 0.3% | — | Healthcare | -0.5% | — | ||
| 6 | Viking Therapeutics, Inc. | $30.38 | 0.3% | $3.52B | -9.5 | -260% | — | Healthcare | 15.6% | — | ||
| 7 | NewAmsterdam Pharma Company N.V. | $29.83 | -1.1% | $3.49B | -17.0 | 5.2% | — | Healthcare | 63.9% | -52.1% | ||
| 8 | Structure Therapeutics Inc. | $44.51 | -1.1% | $2.56B | -18.5 | -2.3% | — | Healthcare | 105.9% | — | ||
| 9 | Septerna, Inc. | $36.17 | 1% | $1.63B | -32.9 | 59.7% | — | Healthcare | 244.8% | 7295.6% | ||
| 10 | MBX Biosciences, Inc. Common Stock | $43.03 | 3.5% | $1.45B | -18.1 | 0% | — | Healthcare | 318.6% | — | ||
| 11 | Maze Therapeutics, Inc. | $25.68 | 3.4% | $1.42B | -8.4 | -4396.9% | — | Healthcare | 128.1% | -88.1% | ||
| 12 | MannKind Corporation | $3.94 | 0.5% | $1.22B | 197.0 | -175.4% | — | Healthcare | 3.4% | 21.2% | ||
| 13 | Lexicon Pharmaceuticals, Inc. | $2.01 | -1.5% | $893M | -14.4 | 86% | — | Healthcare | 169.6% | 123.1% | ||
| 14 | BioAge Labs, Inc. | $20.77 | 3.9% | $747M | -9.3 | 81.7% | — | Healthcare | 373.1% | — | ||
| 15 | Rezolute, Inc. | $5.02 | 4.8% | $483M | -5.1 | 29.3% | — | Healthcare | 23.3% | — | ||
| 16 | Genfit S.A. | $8.95 | 4.1% | $448M | 256.9 | -212.8% | — | Healthcare | 121.5% | 9.8% | ||
| 17 | DiaMedica Therapeutics Inc. | $5.85 | 2.1% | $315M | -8.4 | -10.9% | — | Healthcare | 53.1% | — | ||
| 18 | vTv Therapeutics Inc. | $35.04 | 3.3% | $295M | -11.0 | 100.6% | — | Healthcare | 123.3% | 216600% | ||
| 19 | Niagen Bioscience Inc | $3.50 | 3.9% | $279M | 17.5 | 26.4% | — | Healthcare | -74.6% | 20.8% | ||
| 20 | Altimmune, Inc. | $2.70 | 2.3% | $238M | -2.7 | 26.2% | — | Healthcare | -60.2% | 80% | ||
| 21 | Sagimet Biosciences Inc. | $6.68 | 2.3% | $218M | -4.2 | 23.3% | — | Healthcare | -5.1% | — | ||
| 22 | Galectin Therapeutics Inc. | $2.83 | 2% | $186M | -5.9 | 43.5% | — | Healthcare | -14.1% | — | ||
| 23 | Inventiva S.A. | $3.57 | 1.1% | $186M | -0.9 | -91.2% | — | Healthcare | 6.3% | 15.4% | ||
| 24 | Aardvark Therapeutics, Inc. Common Stock | $3.93 | 2.9% | $86M | -1.5 | -150.8% | — | Healthcare | -67.5% | — | ||
| 25 | Fractyl Health, Inc. Common Stock | $0.86 | 1% | $62M | -0.5 | 5.4% | — | Healthcare | -55.1% | -100% | ||
| 26 | Entera Bio Ltd. | $1.21 | 0.8% | $60M | -4.8 | -164.2% | — | Healthcare | -39.2% | -100% | ||
| 27 | Lipocine Inc. | $2.33 | -2.1% | $13M | -1.4 | -94.1% | — | Healthcare | -27.4% | -45.5% | ||
| 28 | MetaVia Inc. | $1.60 | -6.4% | $4M | -0.2 | 83.7% | — | Healthcare | 128.6% | — | ||
| 29 | Galmed Pharmaceuticals Ltd. | $0.58 | -3.4% | $3M | -0.2 | 97% | — | Healthcare | -67.4% | — | ||
| 30 | Hepion Pharmaceuticals, Inc. | $0.06 | 20% | $698622 | -0.1 | 99.7% | — | Healthcare | -31.8% | — | ||
| 31 | XORTX Therapeutics Inc. | $2.09 | -2.8% | $582042 | -0.1 | -54.6% | — | Healthcare | -51.4% | — |